| Capital Markets Industry | Financials Sector | Mr. David Leslie Breeze CEO | CXA Exchange | - ISIN |
| Australia Country | - Employees | - Last Dividend | 30 Mar 2020 Last Split | - IPO Date |
BPH Energy Limited, initially known as BioPharmica Limited, is a publicly traded company that engages in diverse investments across several industries primarily in Australia. With a foundation year of 2001 and headquartered in Stirling, Australia, the company has broadened its investment horizons to include biotechnology, oil and gas exploration and development, as well as the emergent medicinal cannabis sector. Its endeavors also extend to clean energy solutions, emphasizing the development of a system to generate clean hydrogen and conductive carbon for battery manufacturing. Furthermore, BPH Energy is involved in groundbreaking biomedical research, notably in the area of liver cancer through its investment in the study of the HLS5 tumor suppressor gene. The company also has significant interests in the exploration and development of oil and gas assets within Australia.